Navigation Links
Placebo-controlled Phase IIa Study with the Immunotherapeutic,CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in,Hay Fever Patients

herefore, a significant unmet medical need remains for allergic disease treatment.

Glossary

Allergic rhinitis: a condition due to allergy that mimics a cold. Rhinitis means "inflammation of the nasal mucous membranes".

Alum: commonly used adjuvant in human applications. An adjuvant is administered to enhance an immune response.

Atopic dermatitis: a chronic skin disease; a certain type of eczema. Is accompanied by an inherited tendency to develop allergic diseases.

Conjunctival provocation test: a commonly used allergy test to monitor the allergic disease status of an individual.

Disease-modifying: in contrast to symptomatic treatment, a disease-modifying treatment aims at addressing the cause of disease and modifying the disease progression.

DNA: deoxyribonucleic acid; genetic information of an organism.

Double-blind: a set-up often applied in clinical trials where neither the doctor nor the patient knows if placebo or the active drug substance is applied.

Formulation: the method and process of selecting the components of a mixture. For drugs the term usually describes the way the drug is prepared.

Grass pollen extract: a mixture of allergenic components from grass pollen.

Hay fever: seasonal allergic rhinitis.

Immunotherapy / immunotherapeutic: a therapy aimed at activation of the immune system to modulate a certain disease process.

Conventional immunotherapy for allergic diseases, also termed desensitization, is performed with allergen. CYT003-QbG10 appears to act differently, namely through an allergen-independent mechanism of action in the absence of an added allergen.

Median: a term used in the statistical analysis of a set of numbers; it relates to or constitutes the middle value in a
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... 2011 With the support of Key Opinion Leaders ... the time and attention of KOLs is intensifying. But ... landscape for creating and maintaining KOL and physician relationships. ... KOL landscape, Best Practices, LLC has published an updated ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... of President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, ... urological products and services based in Austin, Texas. ... HealthTronics Group President James Whittenburg, who is staying through ...
Cached Medicine Technology:Pharma Medical Science Liaison Outreach Shifting Away from Traditional Company Sales Regions 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3
(Date:5/25/2013)... New York, NY (PRWEB) May 25, 2013 Country ... was Jason Aldean's opening act in 2012. Due to overwhelming ... countless venues during 2013. , Luke Bryan has written ... a songwriter nearly a decade ago back in the mid-2000 era. ... Billy Currington and Travis Tritt. , When Luke was 14, ...
(Date:5/25/2013)... 25, 2013 According to an article in ... a Feeling,” nearly 30 million Americans tan indoors each year ... despite knowing the health risks. New research suggests ... addictive effect on the brains of some tanners (Go to ... article so I can’t say that I fully support this ...
(Date:5/25/2013)... It's not astonishing that holidays are amongst the most ... from family, friends and co-workers. Between the parties to ... their parents can afford, parties to arrange, and so ... anniversaries and it seems like an eternal cycle of ... and income can’t catch up to the expenses of ...
(Date:5/25/2013)... May 25, 2013 Life science and ... used to detect and create a new substance with ... and are also known as biotechnology reagents. Such reagents ... and education. , This market is driven by factors ... the field of therapeutics, growth in research and rapid ...
(Date:5/25/2013)... New York, New York (PRWEB) May 25, 2013 ... a federal multidistrict litigation underway in U.S. District Court, ... Liebhard LLP reports. According to a Case Management ... procedures that govern the filing of contested motions in ... for filing those motions. (In re: Actos Product Liability ...
Breaking Medicine News(10 mins):Health News:Luke Bryan Tickets: Prices Slashed on Luke Bryan Tickets in Raleigh, Bethel, Camden, Peoria, Nashville, Hartford, Chicago, Boston, Atlanta, Indianapolis & SaratogaSprings 2Health News:Sun Damage – Are UV Rays Addictive? 2Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3
... 17 Carla Bluhm, a developmental psychologist and visiting assistant ... class of 2007, have recently completed a book on the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080220/DC14623 ) , ... Identity and the New Science of Face Transplants" begins with ...
... for Physicians , , VOORHEES, ... infection (CDI) in geriatric and pediatric populations ... in CDI incidence in many age groups, healthcare professionals need ... patient populations. , , To ...
... Dec. 17 minSURG Corporation, along with,its ... NuFix,Inc. ("NuFix"), along with its affiliate Nutech ... settlement of the lawsuits styled Orthopedic,Development Corporation ... Inc., Kenneth Horton and Todd Gilbert, Case ...
... 17 Michelle Aguilar may be the latest,"Biggest Loser" but she ... that when working out hard, it,s important to include the nutrients ... a day provide.,Aguilar is the latest person to lend her upper ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/AQW560 ) , ...
... Labs announces the,availability of its advanced ocular nutrition line ... CVS Pharmacy stores ( www.cvs.com ),nationwide. , ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-b ... marks the first time EyeScience Macular Health Formula(TM) and,EyeScience ...
... improve cognitive impairment, study says , , WEDNESDAY, Dec. ... Alzheimer,s patients, cognitive symptoms are also a safe ... such as aggression, wandering and paranoia, according to ... that examined the effectiveness of three popular cholinesterase ...
Cached Medicine News:Health News:Psychology of Face Transplants is Subject of New Book by Allegheny College Professor 2Health News:Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Alzheimer's Drugs Also Treat Behavioral, Psych Problems 2
... a whole blood control for evaluating the ... measure automated blood cell counts in patient ... RBC and WBC values for the Abbott ... LH750/LH 755 (levels 2 and 3 only) ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: